Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study

No randomized head-to-head comparison of the efficacy and safety of ticagrelor and prasugrel has been published in the 7 years since the higher efficacy of these newer P2Y inhibitors were first demonstrated relative to clopidogrel. This academic study was designed to compare the efficacy and safety...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) Jg. 134; H. 21; S. 1603 - 1612
Hauptverfasser:	Motovska, Zuzana, Hlinomaz, Ota, Miklik, Roman, Hromadka, Milan, Varvarovsky, Ivo, Dusek, Jaroslav, Knot, Jiri, Jarkovsky, Jiri, Kala, Petr, Rokyta, Richard, Tousek, Frantisek, Kramarikova, Petra, Majtan, Bohumil, Simek, Stanislav, Branny, Marian, Mrozek, Jan, Cervinka, Pavel, Ostransky, Jiri, Widimsky, Petr
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 22.11.2016
Schlagworte:	Adenosine - administration & dosage Adenosine - analogs & derivatives Adenosine - therapeutic use Adult Aged Female Humans Middle Aged Myocardial Infarction - drug therapy Myocardial Infarction - pathology Myocardial Infarction - therapy Percutaneous Coronary Intervention - methods Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - administration & dosage Prasugrel Hydrochloride - therapeutic use Ticagrelor percutaneous coronary intervention ticagrelor prasugrel hydrochloride treatment outcome safety myocardial infarction
ISSN:	1524-4539
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!